Efficacy and safety of mirogabalin + opioids vs opioids alone for neuropathic cancer pain: Miro-Canp.

Saved in:
Bibliographic Details
Title: Efficacy and safety of mirogabalin + opioids vs opioids alone for neuropathic cancer pain: Miro-Canp.
Authors: Hashiguchi S; Department of Palliative Medicine, St. Marianna University School of Medicine, Kawasaki, Japan., Matsumoto Y; Department of Palliative Therapy, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Kessoku T; Department of Gastroenterology, International University of Health and Welfare, Chiba, Japan., Kajiura S; Department of Medical Oncology and Palliative Medicine, Toyama University Hospital, Toyama, Japan., Honma H; Department of Palliative Medicine, Niigata Cancer Center Hospital, Niigata, Japan., Yamaguchi T; Department of Palliative Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan., Hasuo H; Department of Psychosomatic Medicine, Kansai Medical University, Osaka, Japan., Takahashi H; Primary Medical Science Department, Medical Affairs Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Yamamoto S; Data Intelligence Department, Global DX, Daiichi Sankyo Co., Ltd., Tokyo, Japan., Satomi E; Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2026 Jan; Vol. 27 (1), pp. 65-75. Date of Electronic Publication: 2026 Feb 25.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7666 (Electronic) Linking ISSN: 14656566 NLM ISO Abbreviation: Expert Opin Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1744-7666
DOI:10.1080/14656566.2026.2627937